Antonio Meijide-Dominguez
Santiago De Compostela, GA, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Angiotensin type-1 receptor autoantibodies promote alpha-synuclein aggregation in dopaminergic neurons.
Journal: Frontiers in immunology
Published: June 30, 2024
Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 09, 2024
Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission.
Journal: NPJ Parkinson's disease
Published: June 28, 2023
Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells.
Journal: Molecular neurobiology
Published: December 22, 2021
Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition.
Journal: The Journal of biological chemistry
Published: December 02, 2021
Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity.
Journal: Frontiers in aging neuroscience
Published: November 30, 2020
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo.
Journal: Neurobiology of disease
Published: November 16, 2020
Pharmacological Modulators of Tau Aggregation and Spreading.
Journal: Brain sciences
Published: October 19, 2020
Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization.
Journal: Scientific reports
Published: January 31, 2020
Synucleinopathies: Where we are and where we need to go.
Journal: Journal of neurochemistry
Published: November 07, 2019
LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders?
Journal: Biochemical Society transactions
Published: March 04, 2019
Last Updated: 09/26/2026